SCHEMBL6923116

SCHEMBL6923116

Cc1cc(CO)cc2c1nc(C)n2CCc1ccc(-c2ccccc2)cc1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DCTPP1 Q9H773 2/20 0.36
DHODH Q02127 1/20 0.36
AGTR1 P30556 5/20 0.36
PPARG P37231 4/20 0.36
AGTR2 P50052 4/20 0.36
KDM4E B2RXH2 1/20 0.36
ABCC3 O15438 1/20 0.36
ABCC4 O15439 1/20 0.36
USP2 O75604 1/20 0.36
ABCB11 O95342 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CHRM2 P08172 1/20 0.36
CYP3A4 P08684 1/20 0.36
ADRA2A P08913 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
CHRM1 P11229 1/20 0.36
CYP2C9 P11712 1/20 0.36
ACE P12821 1/20 0.36
ADRA2C P18825 1/20 0.36
TBXA2R P21731 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6492577 0.91 DCTPP1 (0.41) DCTPP1ALDH1A1MAPK1PDE10ASPHK1
SCHEMBL6498493 0.78 DCTPP1 (0.40) DCTPP1PPARGALDH1A1MAPK1NPSR1
SCHEMBL6923118 0.76 DHODH (0.33) DCTPP1DHODH
SCHEMBL6923121 0.76 DCTPP1 (0.36) DCTPP1DHODHAGTR1PPARG
SCHEMBL6490602 0.76 PPARG (0.41) DCTPP1PPARGCYP2C9NPSR1
SCHEMBL6486764 0.75 DCTPP1 (0.44) DCTPP1DHODHAGTR1PPARGAGTR2
SCHEMBL6489174 0.74 PIK3C2B (0.37) DCTPP1DHODHAGTR1PPARG
SCHEMBL6502677 0.74 P2RX3 (0.40) DCTPP1DHODHPDE10A
SCHEMBL6493027 0.73 MCL1 (0.43) DHODHAGTR1AGTR2
SCHEMBL6501198 0.72 NR4A2 (0.48) DHODHPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004108686-A2 BENZIMIDAZOLE COMPOUNDS HAVING HYPOGLYCEMIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-12-16 WO disclosed